<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Despite their well-established functional roles, <z:chebi fb="0" ids="15358">histone</z:chebi> modifications have received less attention than DNA methylation in the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> field </plain></SENT>
<SENT sid="1" pm="."><plain>In order to evaluate their importance in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), we generated the first genome-wide <z:chebi fb="0" ids="15358">histone</z:chebi> modification profiles in paired <z:mpath ids='MPATH_458'>normal</z:mpath> colon mucosa and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Chromatin immunoprecipitation and microarray hybridization (ChIP-chip) was used to identify promoters enriched for <z:chebi fb="0" ids="15358">histone</z:chebi> H3 trimethylated on lysine 4 (H3K4me3) and lysine 27 (H3K27me3) in paired <z:mpath ids='MPATH_458'>normal</z:mpath> colon mucosa and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples from two <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell line HT29 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: By comparing <z:chebi fb="0" ids="15358">histone</z:chebi> modification patterns in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, we found that alterations predicted to have major functional consequences were quite rare </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, when <z:mpath ids='MPATH_458'>normal</z:mpath> or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue samples were compared to HT29, high similarities were observed for H3K4me3 </plain></SENT>
<SENT sid="5" pm="."><plain>However, the differences found for H3K27me3, which is important in determining cellular identity, indicates that cell lines do not represent optimal <z:e sem="disease" ids="C1519523" disease_type="Experimental Model of Disease" abbrv="">tissue models</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Finally, using public expression data, we uncovered previously unknown changes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> expression patterns </plain></SENT>
<SENT sid="7" pm="."><plain>Genes positive for H3K4me3 in <z:mpath ids='MPATH_458'>normal</z:mpath> and/or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples, which are typically already active in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, became hyperactivated in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, while genes with H3K27me3 in <z:mpath ids='MPATH_458'>normal</z:mpath> and/or <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples and which are expressed at low levels in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, became hypersilenced in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Genome wide <z:chebi fb="0" ids="15358">histone</z:chebi> modification profiles can be used to find epigenetic aberrations in genes associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>This strategy gives further insights into the epigenetic contribution to the oncogenic process and may identify new biomarkers </plain></SENT>
</text></document>